Coherence
Therapeutic neurotechnology that senses and stimulates to keep cancer in check from inside the body
About
Coherence (Coherence Neuro) is a San Francisco neurotechnology company developing AI models and implantable devices that decode the electrical signals linking cancer and the nervous system, and deliver targeted stimulation to slow tumor growth, a field it calls electro-oncology. Its first focus is brain tumors such as glioblastoma. In 2026 it briefly tested its recording implant in three patients during tumor removal surgery at the Royal Melbourne Hospital and is testing recording and stimulation in seven more. In October 2026 it announced a $45 million seed round backed by the OpenAI Startup Fund and Founders Fund to fund a long-term clinical trial. CEO and co-founder: Ben Woodington.
- Website
- coherenceneuro.com
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepagecoherenceneuro.com
For agents
Nothing listed yet.
Products
- SOMA — Coin-sized wireless brain implant designed to monitor cancer and deliver therapeutic stimulation · Hardware